SOURCE: Tara Minerals Corp.

Tara Minerals Corp.

October 02, 2013 09:00 ET

Tara Minerals Releases Additional Gold and Silver Assays

HENDERSON, NV--(Marketwired - Oct 2, 2013) - Tara Minerals Corp. (OTCQB: TARM) (BERLIN: 6T3) is pleased to release additional gold and silver assays from the Idaho Ponderosa Project. These results continue to support Tara's goal of mining the exposed surface portions of the known veins.

The recent samples were taken during bulk sampling of the priority veins at the Ponderosa Project and continued to show encouraging results from the area of interest. Significant assay results from the bulk sampling, exploration trenching and geologic mapping, collected from the mineralized portions of the priority structures, are presented below. Exploration work carried out in two new areas of the project also returned very encouraging results. 

Sample Number Gold opt Silver opt
7-17-6 6.154 0.40
7-22-1 0.660 2.25
7-24-1 1.042 1.45
1743 1.156 0.20
1749 3.584 0.60
1750 0.930 0.18
1753 0.760 0.42
1766 1.156 2.00
1768 0.784 1.40
1771 8.136 1.32
1775 2.525 0.78
1776 0.804 1.10
1778 0.730 0,25
1779 0.672 0.20
1787 2.252 2.48
8-30-13-4 1.360 0.40
8-10-13-3 1.250 0.50
8-13-13-1 0.670 0.25
8-13-13-2 4.614 3.20

The Ponderosa Project consists of 6,721 acres of both patented and unpatented mining claims in central Idaho, USA. The optioned claims include previously mined veins with historic sampling of the exposed outcrops averaging 0.5 oz/t gold.

About Tara Minerals Corp. (

Tara is currently focused on advancing its US and Mexico project pipeline towards 2013 production. In addition to achieving production, management is creating long-term shareholder value and deploying its capital to advance its projects by enhancing resources, further outlining new discoveries/targets, and acquiring additional strategic assets.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. Please read the full disclaimer at (

Contact Information